BOLD vs COF · P/E 0.1, $24.6M cap vs P/E 62, rev $53.43B
Boundless Bio, Inc. Common Stock (BOLD) versus Capital One Financial Corporation (COF) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
BOLD does not have a complete income-statement cache yet.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Not investment advice. Open the BOLD and COF stock pages for the full models.
Not investment advice.